DE69229829D1 - Tumorspezifischer monoklonaler antikörper 81av78 - Google Patents

Tumorspezifischer monoklonaler antikörper 81av78

Info

Publication number
DE69229829D1
DE69229829D1 DE69229829T DE69229829T DE69229829D1 DE 69229829 D1 DE69229829 D1 DE 69229829D1 DE 69229829 T DE69229829 T DE 69229829T DE 69229829 T DE69229829 T DE 69229829T DE 69229829 D1 DE69229829 D1 DE 69229829D1
Authority
DE
Germany
Prior art keywords
tumor
monoclonal antibody
specific monoclonal
monoclonal antibodies
therapy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69229829T
Other languages
English (en)
Inventor
Michael Hanna
Martin Haspel
Herbert Hoover
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HANNA JUN
HOOVER JUN
Per Immune Holdings Inc
Original Assignee
HANNA JUN
HOOVER JUN
Per Immune Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HANNA JUN, HOOVER JUN, Per Immune Holdings Inc filed Critical HANNA JUN
Application granted granted Critical
Publication of DE69229829D1 publication Critical patent/DE69229829D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
DE69229829T 1991-05-16 1992-05-14 Tumorspezifischer monoklonaler antikörper 81av78 Expired - Lifetime DE69229829D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US70128191A 1991-05-16 1991-05-16
PCT/US1992/004023 WO1992020785A1 (en) 1991-05-16 1992-05-14 Tumor associated monoclonal antibody 81av78

Publications (1)

Publication Number Publication Date
DE69229829D1 true DE69229829D1 (de) 1999-09-23

Family

ID=24816733

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69229829T Expired - Lifetime DE69229829D1 (de) 1991-05-16 1992-05-14 Tumorspezifischer monoklonaler antikörper 81av78

Country Status (8)

Country Link
EP (1) EP0584267B1 (de)
JP (1) JPH06508028A (de)
AT (1) ATE183546T1 (de)
AU (1) AU656785B2 (de)
CA (1) CA2108767A1 (de)
DE (1) DE69229829D1 (de)
FI (1) FI935038A0 (de)
WO (1) WO1992020785A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5744585A (en) * 1995-03-16 1998-04-28 Medenica; Rajko D. Human monoclonal antibody against lung carcinoma

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4828991A (en) * 1984-01-31 1989-05-09 Akzo N.V. Tumor specific monoclonal antibodies
NZ210867A (en) * 1984-01-31 1989-01-06 Litton Bionetics Inc Tumour-specific monoclonal antibodies, production thereof and use

Also Published As

Publication number Publication date
AU656785B2 (en) 1995-02-16
FI935038A (fi) 1993-11-15
CA2108767A1 (en) 1992-11-17
ATE183546T1 (de) 1999-09-15
WO1992020785A1 (en) 1992-11-26
EP0584267A4 (de) 1994-11-02
EP0584267B1 (de) 1999-08-18
AU2029892A (en) 1992-12-30
FI935038A0 (fi) 1993-11-15
JPH06508028A (ja) 1994-09-14
EP0584267A1 (de) 1994-03-02

Similar Documents

Publication Publication Date Title
ATE71410T1 (de) Tumorspezifische monoklonale antikoerper.
ATE233102T1 (de) Verfahren und zusammensetzung zur umgestaltung multi-epitopischer antigene um die immunantwort einzuleiten
NZ512722A (en) Use of Ep-CAM antibodies for anticancer vaccination
ATE183546T1 (de) Tumorspezifischer monoklonaler antikörper 81av78
DE68924983T2 (de) Anti-idiotyp antikörper induktion eines antitumorenresponses.
IL86958A0 (en) Human monoclonal antibody igm 16-88,cell lines producing it and antigen recognized thereby
FI924576A (fi) Ctaa 28a32, antigen identiefierad av mca 28a32
NO924803L (no) Tumor-relatert monoklonalt antistoff 88bv59
Triozzi et al. Clinical and immunologic effects of monoclonal antibody CC49 and interleukin-2 in patients with metastatic colorectal cancer
Hellström et al. Mouse Bladder Carcinoma as a Model to Study Immune Manipulations in Man
Fagerberg The idiotypic network response in cancer patients treated with monoclonal antibodies.

Legal Events

Date Code Title Description
8332 No legal effect for de